Medscape

Pharmacologic Therapy for COPD: GOLD or ATS Guidelines?

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. It is a chronic disease that affects quality of life and mobility, and can lead to respiratory ...
Business Wire

The New 2020 Report from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Gives Highest Evidence Rating to Endobronchial Valves, including the Zephyr Valve ...

The New 2020 Report from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Gives Highest Evidence Rating to Endobronchial Valves, including the Zephyr Valve, for Treatment of Emphysema ...
Medscape

Breakthroughs in COPD From the ERS International Congress, 2020

Jadwiga Wedzicha, MD, an expert in respiratory medicine at the National Heart and Lung Institute, London, United Kingdom, discusses key data and the latest guidelines on the management of chronic ...
The American Journal of Managed Care

Study Finds Inconsistencies With GOLD Guidelines Regarding Diagnosis, Treatment of COPD

Based on GOLD 2020 guidelines, investigators found that 117 participants (44.3%) were treated adequately, 8 (3%) were undertreated, and 139 (52.7%) were overtreated. Of 725 participants who had a ...
Business Wire

Boehringer Ingelheim welcomes central role of LAMA/LABA therapy within 2017 GOLD Strategy for COPD

• LAMA/LABA therapy now an essential cornerstone for COPD treatment across the spectrum of people with COPD in GOLD groups B-D 1 INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim welcomes the ...